HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

MEDTIDE

39.380

-1.260-3.10%

Volume:100.80K

Turnover:4.05M

Market Cap:5.59B

PE:83.19

High:41.300

Open:40.640

Low:39.380

Close:40.640

52wk High:41.720

52wk Low:28.100

Shares:142.00M

HK Float Shares:73.60M

Volume Ratio:0.76

T/O Rate:0.14%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.473

ROE:20.67%

ROA:5.25%

PB:16.10

PE(LYR):83.19

PS:11.60

Loading ...

Overview Company News Filings

Hong Kong Stock Alert | MEDTIDE (03880) Surges Over 9% to Record High as Interim Results Approach, Company Ranks as World's Third-Largest Peptide CRDMO

Medtide Inc. Announces Acceptance of H Share Full Circulation Plan Application by China Securities Regulatory Commission

Stock Track | Medtide Soars 5.23% Intraday as Investor Enthusiasm Builds Following Hong Kong IPO

Medtide Nets HK$429 Million from Hong Kong IPO, Prices Shares at Upper Limit of Guidance

MT Newswires Live

BRIEF-Medtide Announces Final Offer Price Under Global Offering HK$30.60 Per H Share

Pharmaceutical Services Firm Medtide Rises 2% in Hong Kong Grey Market Trading

Tiger Newspress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/03880/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"03880","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03880\",,,,,undefined,":{"symbol":"03880","market":"HK","secType":"STK","nameCN":"MEDTIDE","latestPrice":39.38,"timestamp":1756092541926,"preClose":40.64,"halted":0,"volume":100800,"delay":0,"floatShares":73598888,"shares":142000000,"eps":0.473384,"marketStatus":"Trading","change":-1.26,"latestTime":"08-25 11:29:16","open":40.64,"high":41.3,"low":39.38,"amount":4051356,"amplitude":0.047244,"askPrice":39.38,"askSize":100,"bidPrice":39.26,"bidSize":200,"shortable":0,"etf":0,"ttmEps":0.376814,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1756094400000},"marketStatusCode":2,"adr":0,"listingDate":1751212800000,"exchange":"SEHK","adjPreClose":40.64,"openAndCloseTimeList":[[1756085400000,1756094400000],[1756098000000,1756108800000]],"volumeRatio":0.764605,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03880\",,,,,undefined,":{"symbol":"03880","floatShares":73598888,"roa":"5.25%","roe":"20.67%","lyrEps":0.473384,"volumeRatio":0.764605,"shares":142000000,"dividePrice":0,"high":41.3,"amplitude":0.047244,"preClose":40.64,"low":39.38,"week52Low":28.1,"pbRate":"16.10","psRate":"11.60","week52High":41.72,"institutionHeld":0,"latestPrice":39.38,"committee":0.333333,"eps":0.473384,"divideRate":0,"volume":100800,"delay":0,"ttmEps":0.376814,"open":40.64,"prevYearClose":30.6,"prevWeekClose":40.64,"prevMonthClose":35.7,"prevQuarterClose":30.8,"fiveDayClose":35.3,"twentyDayClose":33.7,"sixtyDayClose":30.6,"earningDate":1756396800000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03880\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03880\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03880\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03880\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03880","date":"2025-08-22","current":89.502411,"percent":1,"low":64.550519,"twenty":69.02331,"median":74.090002,"eighty":78.320217,"high":89.502411,"avg":74.609005,"sd":5.259838,"marketCap":5762752000},"quantilePoints":[{"date":"2025-06-27","current":64.550519,"twenty":64.550519,"median":64.550519,"eighty":64.550519,"marketCap":4183100000},{"date":"2025-07-04","current":69.032987,"twenty":66.795355,"median":68.595377,"eighty":69.313609,"marketCap":4473790000},{"date":"2025-07-11","current":68.445519,"twenty":67.311524,"median":68.276633,"eighty":68.994281,"marketCap":4431250000},{"date":"2025-07-18","current":76.171108,"twenty":67.389311,"median":68.984604,"eighty":75.214843,"marketCap":4927550000},{"date":"2025-07-25","current":74.03868,"twenty":67.965697,"median":71.906475,"eighty":74.616858,"marketCap":4807020000},{"date":"2025-08-01","current":77.026259,"twenty":68.377965,"median":73.828208,"eighty":76.342138,"marketCap":4970090000},{"date":"2025-08-08","current":73.611635,"twenty":68.565405,"median":73.719922,"eighty":75.214843,"marketCap":4761644000},{"date":"2025-08-15","current":78.991101,"twenty":68.906759,"median":73.83709,"eighty":76.342138,"marketCap":5101964000},{"date":"2025-08-22","current":89.502411,"twenty":69.02331,"median":74.090002,"eighty":78.320217,"marketCap":5762752000}],"updateTime":1756063163950},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03880\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1182606058","title":"Hong Kong Stock Alert | MEDTIDE (03880) Surges Over 9% to Record High as Interim Results Approach, Company Ranks as World's Third-Largest Peptide CRDMO","url":"https://stock-news.laohu8.com/highlight/detail?id=1182606058","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182606058?lang=en_us&edition=fundamental","pubTime":"2025-08-21 11:12","pubTimestamp":1755745941,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) surged over 9% in morning trading, reaching a high of HK$40.54 and setting a new record since its listing. As of press time, the stock was up 8.9% to HK$40.14, with turnover of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"gpt_icon":0},{"id":"2554748842","title":"Medtide Inc. Announces Acceptance of H Share Full Circulation Plan Application by China Securities Regulatory Commission","url":"https://stock-news.laohu8.com/highlight/detail?id=2554748842","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554748842?lang=en_us&edition=fundamental","pubTime":"2025-07-27 18:25","pubTimestamp":1753611935,"startTime":"0","endTime":"0","summary":"Medtide Inc., a joint stock company incorporated in the People's Republic of China, has announced that the China Securities Regulatory Commission  has accepted its application for the H Share Full Circulation Plan. This regulatory acceptance pertains to the conversion of 68,201,112 unlisted shares into H shares, each with a par value of RMB1.0. This development is a significant step towards the proposed implementation of the full circulation of H shares for certain shareholders of the company. The conversion and listing process will still require adherence to additional procedures mandated by the CSRC, the Hong Kong Stock Exchange, and other relevant regulatory authorities. Medtide Inc. has advised shareholders and potential investors to exercise caution when dealing in the company's securities. Further announcements will be made as details of the conversion and listing are finalized.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligenc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250727:nNDLb80D2T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0},{"id":"1181216476","title":"Stock Track | Medtide Soars 5.23% Intraday as Investor Enthusiasm Builds Following Hong Kong IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1181216476","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181216476?lang=en_us&edition=fundamental","pubTime":"2025-06-30 13:06","pubTimestamp":1751260007,"startTime":"0","endTime":"0","summary":"Medtide Inc. , a peptide-focused CRDMO, is experiencing a significant surge in its stock price during intraday trading on Monday. The company's shares are soaring 5.23%, marking a strong reversal from its initial performance at the market open.This impressive rally comes on the heels of Medtide's recent initial public offering  in Hong Kong. The company successfully raised HK$428.8 million in net proceeds after pricing its shares at HK$30.60, the top end of the indicative price range. The IPO ga","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"6236850a5ccd706a69e00421affe9b09","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Medtide Soars 5.23% Intraday as Investor Enthusiasm Builds Following Hong Kong IPO","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["03880"],"gpt_icon":1},{"id":"2547033547","title":"Medtide Nets HK$429 Million from Hong Kong IPO, Prices Shares at Upper Limit of Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2547033547","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547033547?lang=en_us&edition=fundamental","pubTime":"2025-06-30 07:19","pubTimestamp":1751239152,"startTime":"0","endTime":"0","summary":"Medtide Inc. (HKG:3880) took in HK$428.8 million in net proceeds from its initial public offering in Hong Kong after pricing the shares at the top end of the indicative price range.The peptide-focused","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["03880"],"gpt_icon":1},{"id":"2546476744","title":"BRIEF-Medtide Announces Final Offer Price Under Global Offering HK$30.60 Per H Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2546476744","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546476744?lang=en_us&edition=fundamental","pubTime":"2025-06-27 22:25","pubTimestamp":1751034302,"startTime":"0","endTime":"0","summary":"BRIEF-Medtide Announces Final Offer Price Under Global Offering HK$30.60 Per H ShareJune 27 (Reuters) - Medtide Inc 3880.HK:FINAL OFFER PRICE UNDER GLOBAL OFFERING HK$30.60 PER H SHAREFurther company coverage: 3880.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nFWN3SU0GP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0},{"id":"1135832183","title":"Pharmaceutical Services Firm Medtide Rises 2% in Hong Kong Grey Market Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1135832183","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135832183?lang=en_us&edition=fundamental","pubTime":"2025-06-27 16:20","pubTimestamp":1751012421,"startTime":"0","endTime":"0","summary":"Pharmaceutical services firm $Medtide(03880)$ rose 1% in Hong Kong grey market trading.Medtide was founded in 2020 but a key subsidiary, Zhongtai Biochemical,started operating in 2001 as a peptide-foc","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"6236850a5ccd706a69e00421affe9b09","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}